Nephros (NEPH) Gross Profit Growth (1y) (2011 - 2026)
Nephros (NEPH) Gross Profit Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 21.17% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 3.58% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 20.68% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 5.02% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 16.27% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 20.19% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 9.45% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 8.29% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 4.14% |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 44.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.04% |
| Mar 31, 2026 | -5.10% |
| Dec 31, 2025 | 11.56% |
| Sep 30, 2025 | 35.64% |
| Jun 30, 2025 | 46.18% |
| Mar 31, 2025 | 44.22% |
| Dec 31, 2024 | 22.46% |
| Sep 30, 2024 | -2.05% |
| Jun 30, 2024 | -8.03% |
| Mar 31, 2024 | 3.60% |
| Dec 31, 2023 | 33.93% |
| Sep 30, 2023 | 187.93% |
| Jun 30, 2023 | 49.03% |
| Mar 31, 2023 | 100.47% |
| Dec 31, 2022 | 2.58% |
| Sep 30, 2022 | 1,365.38% |
| Jun 30, 2022 | 9.41% |
| Mar 31, 2022 | -33.65% |
| Dec 31, 2021 | 12.98% |
| Sep 30, 2021 | -95.76% |